SCHEMBL3919310

SCHEMBL3919310

CC#CCCc1ccccc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.49
MAOB P27338 5/20 0.44
MAOA P21397 3/20 0.44
FFAR1 O14842 1/20 0.44
FFAR4 Q5NUL3 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
ALOX12 P18054 1/20 0.44
CASP1 P29466 1/20 0.44
HSD17B10 Q99714 1/20 0.44
KCNH2 Q12809 1/20 0.44
TAAR1 Q96RJ0 3/20 0.43
ATM Q13315 1/20 0.43
TDP1 Q9NUW8 2/20 0.42
CYP2A6 P11509 1/20 0.42
HTR2A P28223 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
LOXL2 Q9Y4K0 1/20 0.42
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29048463 0.86 GRM5 (0.51) GRM5MAOBMAOAKCNH2
SCHEMBL9303814 0.85 ALDH1A1 (0.52) GRM5MAOBMAOAFFAR1FFAR4
SCHEMBL5904234 0.80 MAOB (0.48) GRM5MAOBMAOAALDH1A1HPGD
SCHEMBL6738643 0.80 ALDH1A1 (0.48) GRM5MAOBMAOAFFAR1FFAR4
SCHEMBL25047571 0.80 SIGMAR1 (0.55) KCNH2TAAR1ATM
SCHEMBL27379751 0.79 GRM5 (0.33) GRM5KCNH2
SCHEMBL6256644 0.79 FFAR1 (0.43) GRM5MAOBMAOAFFAR1FFAR4
SCHEMBL9784188 0.79 KCNH2 (0.50) GRM5FFAR1FFAR4ALDH1A1HPGD
SCHEMBL8041091 0.77 PYCR1 (0.36) KCNH2
SCHEMBL8042787 0.77 PYCR1 (0.52) MAOBTAAR1CYP2A6HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0078145-B1 RESOLUTION OF RACEMIC 5-PHENYL-2-PENTANOL PFIZER INC. (US) 1986-07-30 EP claimed
EP-2038278-A2 THIAZOLINE AND OXAZOLINE DERIVATIVES AND THEIR METHODS OF USE Abbott Laboratories (US) 2009-03-25 EP disclosed
WO-2008002956-A2 THIAZOLINE AND OXAZOLINE DERIVATIVES AND THEIR METHODS OF USE ABBOTT LABORATORIES (US) 2008-01-03 WO disclosed
EP-1677789-A1 ALKYNES I AstraZeneca AB (SE) 2006-07-12 EP disclosed
CN-1787996-A Nitrogen-containing heterocyclic derivative and drug containing the same as active ingredient ONO PHARMACEUTICAL CO (JP) 2006-06-14 CN disclosed
WO-2005044266-A1 ALKYNES I ASTRAZENECA AB (SE) 2005-05-19 WO disclosed
EP-1451159-A1 COMPOSITIONS DERIVED FROM QUINOLINE AND QUINOXALINE, PREPARATION AND USE THEREOF NEURO3D (FR) 2004-09-01 EP disclosed
WO-2003010146-A1 COMPOSITIONS DERIVED FROM QUINOLINE AND QUINOXALINE, PREPARATION AND USE THEREOF NEURO3D (FR) 2003-02-06 WO disclosed
CN-1135515-A Liquid crystal alkynyl tolane compound, liquid crystal composition and liquid crystal display part CHISSO CORP (JP) 1996-11-13 CN disclosed